|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 856873
Online Users : 951
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/6056
|
Title: | Bacteremia due to extended-Spectrum-beta-Lactamase-Producing Aeromonas spp. at a Medical Center in Southern Taiwan |
Other Titles: | Bacteremia due to extended-Spectrum-β-Lactamase-Producing Aeromonas spp. at a Medical Center in Southern Taiwan |
Authors: | Wu, CJ;Chuang, YC;Lee, MF;Lee, CC;Lee, HC;Lee, NY;Chang, CM;Chen, PL;Lin, YT;Yan, JJ;Ko, WC |
Contributors: | Division of Infectious Diseases |
Abstract: | Although extended-spectrum β-lactamase (ESBL)-producing aeromonads have been increasingly reported in recent years, most of them were isolates of case reports or environmental isolates. To investigate the prevalence of ESBL-producers among Aeromonas blood isolates and the genes encoding ESBLs, consecutive non-duplicated Aeromonas blood isolates collected at a medical center in southern Taiwan from March 2004 to December 2008 were studied. The ESBL phenotypes were examined by clavulanate combination disk test and the cefepime-clavulanate ESBL Etest. Presence of ESBL-encoding genes, including blaTEM, blaPER, blaCTX-M, and blaSHV genes, were evaluated by polymerase chain reaction and sequence analysis. The results showed that four (2.6%) of 156 Aeromonas blood isolates, one A. hydrophila isolate and three A. caviae isolates, expressed an ESBL-producing phenotype. The ESBL gene in two A. caviae isolates was blaPER-3 gene, which was located in both chromosomes and plasmids demonstrated by Southern hybridization. Of four patients with ESBL-producing Aeromonas bacteremia, two presented with catheter-related phlebitis and the other two primary bacteremia. Three patients had been treated with initial non-carbapenem β-lactams for 5-10 days, and all survived. In conclusion, the ESBL producers among Aeromonas blood isolates exists, clinical suspicion of ESBL production should be raised in treating infections due to cefotaxime-resistant Aeromonas isolates. |
Date: | 2011-12 |
Relation: | Antimicrobial Agents and Chemotherapy. 2011 Dec;55(12):5813-5818. |
Link to: | http://dx.doi.org/10.1128/aac.00634-11 |
JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR |
Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000296920600052 |
Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=81555206716 |
Appears in Collections: | [吳綺容] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
PB2011110411.pdf | | 579Kb | Adobe PDF | 430 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|